
09/30/2025
A study by MIT researchers is revolutionizing HIV vaccine development.
Traditionally, a seven-dose regimen has been used to generate a strong immune response. However, the team found that a two-dose schedule can produce equally strong antibody and T-cell responses, paving the way for more practical vaccination methods.
Strategies like these are essential for global vaccination efforts.
MIT researchers have shown that they can generate a strong immune response against HIV with two doses of a vaccine given one week apart.